Prenatal xenobiotic exposure and intrauterine hypothalamus-pituitary-adrenal axis programming alteration

Toxicology. 2014 Nov 5:325:74-84. doi: 10.1016/j.tox.2014.08.015. Epub 2014 Sep 4.

Abstract

The hypothalamic-pituitary-adrenal (HPA) axis is one of the most important neuroendocrine axes and plays an important role in stress defense responses before and after birth. Prenatal exposure to xenobiotics, including environmental toxins (such as smoke, sulfur dioxide and carbon monoxide), drugs (such as synthetic glucocorticoids), and foods and beverage categories (such as ethanol and caffeine), affects fetal development indirectly by changing the maternal status or damaging the placenta. Certain xenobiotics (such as caffeine, ethanol and dexamethasone) may also affect the fetus directly by crossing the placenta into the fetus due to their lipophilic properties and lower molecular weights. All of these factors probably result in intrauterine programming alteration of the HPA axis, which showed a low basal activity but hypersensitivity to chronic stress. These alterations will, therefore, increase the susceptibility to adult neuropsychiatric (such as depression and schizophrenia) and metabolic diseases (such as hypertension, diabetes and non-alcoholic fatty liver disease). The "over-exposure of fetuses to maternal glucocorticoids" may be the main initiation factor by which the fetal HPA axis programming is altered. Meantime, xenobiotics can directly induce abnormal epigenetic modifications and expression on the important fetal genes (such as hippocampal glucocorticoid receptor, adrenal steroidogenic acute regulatory protein, et al) or damage by in situ oxidative metabolism of fetal adrenals, which may also be contributed to the programming alteration of fetal HPA axis.

Keywords: Epigenetic modifications; Hypothalamic–pituitary–adrenal axis; In situ oxidative metabolism damage; Intrauterine programming; Xenobiotics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Age Factors
  • Animals
  • Epigenesis, Genetic / drug effects
  • Female
  • Gene Expression Regulation, Developmental / drug effects
  • Gestational Age
  • Humans
  • Hypothalamo-Hypophyseal System / drug effects*
  • Hypothalamo-Hypophyseal System / embryology
  • Hypothalamo-Hypophyseal System / metabolism
  • Hypothalamo-Hypophyseal System / physiopathology
  • Maternal Exposure / adverse effects*
  • Pituitary-Adrenal System / drug effects*
  • Pituitary-Adrenal System / embryology
  • Pituitary-Adrenal System / metabolism
  • Pituitary-Adrenal System / physiopathology
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Risk Assessment
  • Risk Factors
  • Xenobiotics / adverse effects*

Substances

  • Xenobiotics